Free Trial

Cadrenal Therapeutics (CVKD) Institutional Ownership

$0.43
+0.02 (+4.87%)
(As of 05/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Cadrenal Therapeutics (NASDAQ:CVKD)

Current
Institutional Ownership
Percentage
7.92%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$668.05K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$420.26K
Get CVKD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Cadrenal Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024 Armistice Capital LLC414,285$307K0.0%-57.8%3.182%
11/15/2023 Armistice Capital LLC982,285$668K0.0%N/A7.544%
(Data available from 1/1/2016 forward)

CVKD Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CVKD shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cadrenal Therapeutics shares: Armistice Capital LLC ($307K).Learn more on CVKD's institutional investors.

What percentage of Cadrenal Therapeutics stock is owned by institutional investors?

7.92% of Cadrenal Therapeutics stock is owned by institutional investors. Learn more on CVKD's institutional investor holdings.

Which institutional investors have been buying Cadrenal Therapeutics stock?

The following institutional investors have purchased Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($982.29K).

How much institutional buying is happening at Cadrenal Therapeutics?

Institutional investors have bought a total of 982,285 shares in the last 24 months. This purchase volume represents approximately $668.05K in transactions.

Which Cadrenal Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($568K).

How much institutional selling is happening at Cadrenal Therapeutics?

Institutional investors have sold a total of 568,000 shares in the last 24 months. This volume of shares sold represents approximately $420.26K in transactions.


This page (NASDAQ:CVKD) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners